ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

30846 results sorted by trial registration date.
  • Implementation of a mindfulness program targeting resilience and staff burnout in aged care services

    This proposal targets retention of the aged care workforce by implementing a mindfulness program to increase staff resilience and work engagement, while decreasing stress and burnout. The intervention is the Mindfulness In Motion (MIM) program. This is an eight week online evidence-based mindfulness and yoga intervention. The program has been delivered to a range of health care staff across a variety of settings in the US. This project will be the first Australian study to deliver and evaluate the MIM program and the first in a residential aged care setting. We will work with a Tasmanian Aged Care provider to codesign a bespoke implementation strategy that will support the translation of the MIM program into five residential aged care facilities. We will use a type 2 hybrid implementation design to assess the effectiveness of a) the MIM program on staff outcomes (burnout, stress, work engagement, resilience and turnover) and b) the codesigned implementation strategy. This project aims to assess the potential for translating the successful MIM program into residential aged care services as a feasible and acceptable intervention to reduce staff burnout and enhance staff retention.

  • Examination of respiratory mechanics with trunk inclination in obese and non-obese ARDS patients

    The aim of our study is to measure the effect of trunk inclination on partition respiratory mechanics and gas exchange in a cohort of obese and non-obese mechanically ventilated ARDS patients.

  • Get A Grip: Spinal stimulation for upper limb and respiratory function in incomplete tetraplegia

    Fifty five percent of all spinal cord injuries result in tetraplegia with impaired motor and sensory function of arms, hands, legs and respiratory muscles. For people with tetraplegia, restoration of hand and arm function ranks highest of all functional recovery targets, closely followed by improved breathing and coughing. Exercise training is the main treatment for improving upper-limb and respiratory function after spinal cord injury. Emerging evidence from pre-clinical and clinical studies suggests transcutaneous spinal cord neuro-stimulation (TSS), increases spinal cord excitability through increased reflex input. The aim of this study is to explore the efficacy, safety, and acceptability of TSS combined with exercise training for chronic tetraplegia, targeting hand and respiratory function. The study will be a multi-centred community-based adaptive Bayesian Optimal Phase (BOP) II trial design across Australia. A BOP trial design allows for early analysis, identifying and ceasing trial arms that prove to be futile to continue. We hypothesise participants with incomplete tetraplegia will improve in their strength and breathing outcome measures, to reach the pre-determined signal of benefit.

  • Moves Like Jagger - Acceptability of an in-person 12-week movement program (Motum) in addressing functional outcomes in people with chronic non-specific low back pain

    The purpose of this study is to assess how acceptable those with NSLBP symtpoms find the Motum program to be as in intervention to improve their function and pain. After participating in the Motum program (a ground based exercise class, 12 x 1 hour classes, 1 per week), participants will complete the questionnaires listed previously and the YBT as outcome measures.

  • A Randomised, Double-Blind and Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIR9900 after Oral Administrations in Healthy Elderly Volunteers. (Multiple Ascending Dose (MAD), Part 2 Cohort 5).

    This will be a single-centre, randomised, double-blind, placebo-controlled, and sequential cohort study to evaluate the safety, tolerability, PK and PD of multiple ascending doses of SIR9900 after oral administrations in healthy elderly volunteers. One cohort of male and female healthy elderly volunteers aged greater than or equal to 65 years in Part 2 MAD, at the time of screening are eligible for recruitment. Part 2 MAD participants will have a screening period of up to 28 days and be required on-study for approximately 3 weeks post-dose. SIR9900 is a potent and selective allosteric RIPK1 inhibitor being developed for the potential treatment of inflammatory, autoimmune, and degenerative diseases, particularly in the central nervous system.

  • Evaluating the patient experience of orthodontic treatment using virtual monitoring and digital technology for rural and metropolitan public patients in NSW.

    The study aims to trial a remote care model which should give remote patients earlier and better access to orthodontic care using their local dentist and an application, supported by an orthodontist remotely. This is a Quasi-Experimental trial to investigate the efficacy of a virtual care model, using artificial intelligence (AI) to provide orthodontic treatment by dentists to public rural and metropolitan NSW patients, while under the remote supervision of orthodontists, in comparison to conventional face-to-face treatment provided by specialists. Participants: Up to 90 patients, aged 8-18 years, who are eligible to receive orthodontic treatment in the public system and meet the orthodontic treatment severity criteria will be selected. Treatment will be done using aligners with Dental Monitoring (DM Group) and compared to treatment using aligners without DM (Positive Control Group) and conventional braces treatment without DM (Negative Control Group).

  • A monocentric, retrospective and prospective, non-randomised, clinical survey to evaluate Mpact cup performance 5 years following Total hip arthroplasty

    Mpact cup is a modular hemispherical press-fit acetabular shell with an external Titanium porous coating called Ti-Growth (Medacta commercial name: MectaGrip). The primary objective of this study is to evaluate Mpact clinical and radiological performance through modified HHS and standard X-rays. The secondary objectives are to evaluate five-year survival rate of the Mpact cup and to quantify and document any associated complications

  • A First-in-human Study of APG777 in Healthy Participants

    The purpose of the study is to assess the safety, tolerability and pharmacokinetics of APG777 following single and multiple subcutaneous (SC) administration to healthy participants.

  • RESHAP-ED: comparing primary-contact physiotherapy with standard care for musculoskeletal conditions in emergency departments.

    Musculoskeletal conditions, including low back pain, are among the top 10 reasons for presentation to Australian emergency departments (EDs). Current evidence have shown that timely access to physiotherapy in EDs reduces wait-time, and overall ED length of stay. Primary-contact physiotherapists have been present in some Australian EDs for approximately 20 years, however the level of service provision varies across sites and access is inequitable. This may be because strong evidence of effectiveness is lacking, i.e. predominately observational studies or trials of low quality. The RESHAP-ED trial will determine the effectiveness, cost-effectiveness, and scalability of a primary-contact physiotherapy service when compared to usual care (doctors and nurses service) in managing musculoskeletal conditions in the ED. Our hypothesis is that a primary-contact physiotherapy pathway in the emergency department, to assess and manage patients who present with musculoskeletal conditions, will reduce time spent in emergency departments.

  • A trial to assess the visual performance of myopia management contact lenses in adults

    The purpose of this study is to assess the visual performance of prototype contact lenses with a tinted edge pattern compared to commercially available single vision contact lens and myopia management contact lens.

Tags:
  • Finding clinical trials